Login to Your Account

Financings Roundup

Tuesday, January 31, 2012

• Trius Therapeutics Inc., of San Diego, said underwriters of its previously announced public offering exercised in full their option to purchase an additional 1.29 million shares to cover overallotments. Including the overallotment, the company grossed $51.9 million from the sale of 9.89 million shares priced at $5.25 apiece.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription